GEN Where do you see possibilities for growth in the current biotech market?
Reinhard Vogt: Some people say biotech is only about monoclonal antibodies and recombinant proteins. But to us, vaccines and blood fractionation are extremely important. The vaccine industry is growing, and this particular industry is receptive to disposables because the volumes are much smaller than for other bioproducts, and vaccines are often manufactured during vaccine campaigns (e.g., before the flu season). Disposables also help eliminate the risk of cross-contamination and provide a high degree of flexibility.
With companies like Sanofi Pasteur, Novartis, GlaxoSmithKline, and Merck investing in new vaccines, and with several Asian firms making traditional vaccines for their local populations, you can see why the size of this market is increasing.